Nilotinib-mediated inhibition of ABCB1 increases intracellular concentration of dasatinib in CML cells: implications for combination TKI therapy.
| Autor: | Hiwase, D K1, White, D1, Zrim, S2, Saunders, V2, Melo, J V1, Hughes, T P1 |
|---|---|
| Zdroj: | Leukemia (08876924). Mar2010, Vol. 24 Issue 3, p658-660. 3p. 1 Chart, 2 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|